Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040110755A1
SERIAL NO

10638702

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical combinations therapies based on p38 kinase inhibitors and another active ingredient, pharmaceutical compositions comprising such combinations, processes for preparing them and their use in the treatment of cytokine mediated diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOEHRINGER INGELHEIM PHARMA GMBH & CO KGBINGER STRASSE 173 INGELHEIM 55216
BOEHRINGER INGELHEIIM PHARMACEUTICALS INC900 RIDGEBURY ROAD RIDGEFIELD CT 06877
BOEHRINGER INGELHEIM - FRANCE12 RUE ANDRE HUET BP292 51060 REIMS CEDEX

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bilbault, Pascal Reims, FR 2 6
Cappola, Michael L Wilton, CT 12 51
Simianer, Stefan Mittelbiberach, DE 2 6
Way, Susan Lynn Danbury, CT 4 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation